The company
OmniAb, Inc.
OABI · Nasdaq
OABI stood above a rising 150-day average in 31 of the last 52 weekly readings, including each of the last 23 weeks. It is 66.5% above that average now. Life Science Tools & Research Services: 48% of its 79 stocks in an uptrend (−5 points in four weeks); Health Care: 28% (−6 points in four weeks).
Statistics
- Rotation
- Leading
- Weeks in an uptrend
- 23 in a row
- Industry in uptrend
- 48% -5 in 4 wk
- Insider buys, 12 months
- $108K
- Insider sales, 12 months
- $477K
- Officials’ trades on record
- 0
- Institutions holding
- 127 (+3)
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 31 of 52 weeks.
Life-science tools: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has been slipping.
Money in and out
Open-market buys above the line and sales below, in dollars.
Congress and officials
No member of Congress or official has disclosed a trade in it.
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Charles S. BerkmanChief Legal Officer | sold | 7,157at $1.49 | 7 Apr 2026filed 7 Apr 2026 |
| Kurt A. GustafsonExecutive VP, Finance and CFO | sold | 6,913at $1.49 | 7 Apr 2026filed 7 Apr 2026 |
| Matthew W. FoehrPresident and CEO | sold | 19,244at $1.49 | 7 Apr 2026filed 7 Apr 2026 |
| Matthew W. FoehrPresident and CEO | sold | 30,843at $1.71 | 18 Feb 2026filed 18 Feb 2026 |
| Charles S. BerkmanChief Legal Officer | sold | 9,673at $1.71 | 18 Feb 2026filed 18 Feb 2026 |
| Kurt A. GustafsonExecutive VP, Finance and CFO | sold | 9,301at $1.71 | 18 Feb 2026filed 18 Feb 2026 |
| Charles S. BerkmanChief Legal Officer | sold | 6,990at $1.70 | 17 Feb 2026filed 17 Feb 2026 |
| Kurt A. GustafsonExecutive VP, Finance and CFO | sold | 6,828at $1.70 | 17 Feb 2026filed 17 Feb 2026 |
| Matthew W. FoehrPresident and CEO | sold | 20,754at $1.70 | 17 Feb 2026filed 17 Feb 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.
| Manager | Shares | Change |
|---|---|---|
| Whitefort Capital Management, LPreduced · filed 14 Aug 2026 | 10,248,658$25.2M | -3,975,000−27.9% |
| BlackRock, Inc.added · filed 7 Aug 2026 | 8,897,490$21.9M | +790,609+9.8% |
| NOMURA HOLDINGS INCadded · filed 14 Aug 2026 | 5,028,160$12.4M | +4,323,112+613.2% |
| CADIAN CAPITAL MANAGEMENT, LPadded · filed 14 Aug 2026 | 4,211,821$10.4M | +54,692+1.3% |
| VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 2026 | 3,852,356$9.5M | -141,296−3.5% |
| GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 2026 | 2,883,978$7.1M | -41,601−1.4% |
| RICE HALL JAMES & ASSOCIATES, LLCadded · filed 7 Aug 2026 | 2,610,434$6.4M | +63,179+2.5% |
| PRIVATE MANAGEMENT GROUP INCreduced · filed 31 Jul 2026 | 2,344,770$5.8M | -84,396−3.5% |
| STATE STREET CORPadded · filed 7 Aug 2026 | 2,133,549$5.2M | +66,406+3.2% |
| DIMENSIONAL FUND ADVISORS LPreduced · filed 11 Aug 2026 | 1,262,099$3.1M | -483,149−27.7% |
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
No federal award is tied to it.
From its SEC filings
Analyst forecasts
No analyst forecasts yet.